Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | Importance of biomarkers when evaluating heterogeneity in HER2+ metastatic BC

Maria Vittoria Dieci, MD, of the University of Padua, Padova, Italy, reviews how current biomarkers are used in the stratification of HER2+ metastatic breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).